Morphologic and cytochemical characteristics of acute promyelocytic leukemia
- 1 April 1989
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 30 (4) , 221-227
- https://doi.org/10.1002/ajh.2830300406
Abstract
The existence of two distinct subtypes of acute promyelocytic leukemia was confirmed and characterized based on morphologic features of leukemic cells in a series of 63 patients studied by the Cancer and Leukemia Group B (CALGB). Seventeen patients (27%) had microgranular leukemic cells (M3V), and 46 patients (73%) had hypergranular leukemic cells (M3). These patient cohorts were studied for other laboratory and clinical features. Leukemic cells from M3V patients stained less frequently than leukemic cells from M3 patients for myeloperoxidase (median, 93% vs. 99%; P=.006), periodic acid‐Schiff (median, 57% vs. 92%; P=.0001), ASD‐chloroacetate esterase (median, 45% vs. 87%; P<.0001), and alpha‐naphthyl acetate esterase (0% vs. 37%; P=.003). Patients with M3V had a higher platelet count (median, 50 vs. 30 × 109/L; P=.01) and tended to have a higher leukocyte count (median, 7.4 vs. 2.2 × 109/L; P=.06) than M3 patients. The patients with M3V morphology were more likely to be nonwhite (29% vs. 7%; P=.03), female (71% vs. 37%; P=.02), and to be infected at the time of presentation (71% vs. 35%; P=.02). No differences in the frequency of the t(15;17) karyotype or the immunopheno‐typic expression of the leukemic cells were noted in the two morphologic subtypes of acute promyelocytic leukemia. Fewer patients with M3V tended to enter complete remission (65% vs. 80%; P=.20), but no significant differences were found in the duration of complete remission (P=.81; 1 year rate, 50% vs. 85%), or probability of survival (P=.67; 1 year rate, 49% vs. 68%).Keywords
This publication has 31 references indexed in Scilit:
- Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patientsBlood, 1988
- A monoclonal antibody that blocks class II histocompatibility-related immune interactionsHuman Immunology, 1984
- Acute promyelocytic leukaemia: a study of 39 cases with identification of a hyperbasophilic microgranular variantBritish Journal of Haematology, 1982
- "Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entityBlood, 1980
- A VARIANT FORM OF HYPERGRANULAR PROMYELOCYTIC LEUKAEMIA (M3)British Journal of Haematology, 1980
- Acute promyelocytic leukemiaAmerican Journal of Hematology, 1979
- Acute Promyelocytic LeukemiaArchives of internal medicine (1960), 1978
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976
- Hypergranular Acute Promyelocytic Leukaemia with Intravascular CoagulationScandinavian Journal of Haematology, 1973
- An improved method of staining leucocyte granules with sudan black BThe Journal of Pathology and Bacteriology, 1947